Medline
$35.61Change from previous close: +1.92%Absolute change: +$0.67
At a glance
- Net margin
- 4.1%
- 2025
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Total revenue | 7,685 | 7,352 | 7,787 | — | — | 6,644 |
| Cost of revenue | 5,470 | 5,511 | 5,873 | — | — | 4,820 |
| Gross profit | 2,215 | 1,841 | 1,914 | — | — | 1,824 |
| Selling, general and administrative | 1,295 | 1,228 | 1,265 | — | — | 1,070 |
| Operating income | 395 | 422 | 425 | — | — | 571 |
| EBIT | 403 | 456 | 372 | — | 612 | 582 |
| EBITDA | 659 | 710 | 633 | — | 862 | 829 |
| Interest expense | 168 | 165 | 166 | — | 253 | 244 |
| Pre-tax income | 235 | 291 | 206 | — | — | 338 |
| Income tax | 96.0 | 52.0 | 26.0 | — | — | 16.0 |
| Net income | 60.0 | 129 | 182 | — | — | 322 |
| Net income to common shareholders | 59.0 | 132 | 182 | — | — | 322 |
| Basic EPS | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | — |
| Diluted EPS | 0.07 | 0.16 | -0.01 | 0.18 | 0.42 | — |
| Average shares (basic) | 857 | 819 | 810 | 1,828 | 800 | — |
| Average shares (diluted) | 861 | 825 | 810 | 1,828 | 800 | — |